Skip to main content
PLOS One logoLink to PLOS One
. 2024 Feb 26;19(2):e0299462. doi: 10.1371/journal.pone.0299462

Linguistic analysis of health anxiety during the COVID-19 pandemic

Alexandra D Peterson 1,#, Mindy M Kibbey 2,#, Samantha G Farris 2,*,#
Editor: Syed Hassan Ahmed3
PMCID: PMC10896548  PMID: 38408056

Abstract

Health anxiety, which is defined as fear of having or contracting serious physical illness, is particularly salient in light of the COVID-19 pandemic. We conducted a mixed methods study in which 578 narrative samples were analyzed using Linguistic Inquiry and Word Count (LIWC) software to determine linguistic markers from six LIWC categories relevant to cognitive-behavioral features of health anxiety. Broad linguistic predictors were analyzed through three backward elimination regression models in order to inform subcategory predictors of each area of health anxiety. Thus, both broad and specific linguistic predictors of general health anxiety, virus-relevant body vigilance, and fears of viral contamination were examined. Greater use of affective category words in written narratives predicted general health anxiety, as well as body vigilance and viral contamination fears. These findings represent the first direct demonstration of linguistic analysis of health anxiety and provide nuanced information about the nature and etiology of health anxiety.

Introduction

The impact of the coronavirus disease 2019 (COVID-19) pandemic and subsequent infection control restrictions has led to elevated levels of anxiety across the global population, due to both actual (e.g., viral infection) and perceived (e.g., fear of viral infection) threats [1]. Pre-existing daily stressors coupled with the additional stressors associated with the COVID-19 pandemic (e.g., social isolation, financial instability, food insecurity) can create a compounded effect of distress [2]. While some individuals remain resilient to highly stressful events such as widespread viral outbreaks, those who respond with excessive anxiety—including individuals prone to health anxiety—are at greater risk for prolonged distress [3]. In fact, “COVID Stress Syndrome” has been proposed as a pandemic-related adjustment disorder marked by clinically significant levels of distress and functional impairment [3]. While an adjustment disorder marks development of behavioral or emotional symptoms in response to an identifiable stressor—that are out of proportion to the intensity of that stressor [4]—COVID Stress Syndrome is a recently proposed adjustment disorder specific to the SARSCoV2 infection, with identifiable domains including: fear of viral infection, excessive worry about the pandemic, and pandemic-related traumatic stress symptoms [5]. These symptoms share characteristics of health anxiety.

Health anxiety is characterized by fears of being exposed to and contracting a serious illness, or, the belief that one has already developed a serious disease or medical condition [6]. More broadly, health anxiety can refer to the tendency to over-attend to and become alarmed by health-related stimuli [4], and ranges on a continuum from mild to severe. While mild to moderate health anxiety may be adaptive and lead to engagement in appropriate health and safety measures, people with severe health anxiety frequently exhibit high levels of functional impairment, as well as overutilization of healthcare services [7, 8]. Clinically elevated health anxiety is regularly expressed as persistent worry and maladaptive beliefs about health-related stimuli, along with excessive engagement in subsequent compensatory behaviors (e.g., excessive handwashing, reassurance-seeking). Lifetime prevalence of clinically elevated health anxiety ranges from 1.3% to 10% in the general population [4]. Studies have shown that elevated health anxiety is a transdiasgnostic vulnerability factor exhibited in multiple DSM-5 psychiatric disorders such as illness anxiety disorder and somatic symptom disorder as well as panic disorder and obsessive-compulsive disorder [4, 9].

Heightened body vigilance, which is often a feature of health anxiety, is particularly relevant during widespread viral outbreaks, as individuals may misinterpret somatic stress reactions (e.g., shortness of breath, fatigue, increased muscle tension) as signs of infection [10, 11]. Increased engagement in safety seeking behaviors (SSB) is also common during acute viral events. SSB, as discussed by Salkovskis [12], refer to activities that exceed necessary safety precautions and/or that individuals engage in to feel safe—reinforcing the belief that the only reason one remained safe is due to their engagement in these unnecessary and ‘false’ safety behaviors. One study observed that precautionary behaviors, such as using hand sanitizer and avoiding social events, are commonly exhibited by individuals affected by the COVID-19 pandemic [13]. However, while engagement in these behaviors may be adaptive and aligned to public health recommendations, higher levels of engagement were found to be correlated with heightened levels of anxiety and stress [13], suggesting that elevated worry and psychological distress is linked to excessive engagement in SSB.

Linguistic analysis of COVID-19 distress is an emerging area of research [14, 15], and published research detailing linguistic analysis of health anxiety in the context of the COVID-19 pandemic is limited [16]. Linguistic analysis has shown that the words individuals use can indicate and even predict health behavior and mental illness. However, few studies have examined linguistic markers of anxiety. Extant findings do suggest a level of attentional self-focus associated with symptoms of anxiety, as indicated by the use of first-person singular pronouns [17, 18]. Linguistic analysis of verb tense yields information about the temporal focus of attention, which is relevant to worry and anxiety processes. According to Borkovec’s [19] view, engaging in worry represents an individual’s attempt to prevent hypothetical negative events from occurring, and, in turn, contributes to a perceived sense of control over the threat. Thus, people who frequently engage in worry may focus their attention—and, therefore, their word use—on the future, as opposed to in the present. Indeed, use of future-tense words has been shown to be a significant predictor of generalized anxiety disorder diagnosis [20]. However, no published studies to our knowledge have examined linguistic predictors specific to health anxiety.

Therefore, the primary aim of the current study was to assess broad linguistic predictors of general health anxiety in the context of the COVID-19 pandemic. We hypothesized that use of words from the broad LIWC categories of affective, cognitive, and perceptual word processes would predict elevated general health anxiety. Specifically, we expected that anxiety-related words would predict elevated general health anxiety, based on previous findings in the literature [18]. For a list of selected LIWC categories and word examples, see Table 1.

Table 1. LIWC categories of health anxiety.

Process of Health Anxiety Example Words Mean (SD)
Affective processes happy, cried 5.8 (1.7)
Positive emotion love, nice 2.0 (1.1)
Negative emotion hurt, nasty 3.5 (1.4)
Anxiety worried, fearful 1.9 (1.0)
Anger hate, annoyed 0.3 (0.4)
Sadness crying, sad 0.6 (0.6)
Cognitive processes cause, ought 13.6 (2.7)
Insight think, know 2.5 (1.1)
Causation because, effect 2.7 (1.2)
Discrepancy should, would 1.3 (0.8)
Tentative maybe, perhaps 3.1 (1.3)
Certainty always, never 1.7 (0.9)
Differentiation hasn’t, but 3.8 (1.4)
Perceptual processes look, heard 1.7 (0.9)
See view, saw 0.5 (0.5)
Hear listen, hearing 0.1 (0.3)
Feel feels, touch 1.0 (0.7)
Biological processes eat, pain 2.7 (1.4)
Body hands, spit 0.5 (0.5)
Health clinic, flu 1.9 (1.0)
Sexual love, horny 0.01 (0.1)
Ingestion dish, eat 0.3 (0.5)
Drives take, social 7.9 (2.0)
Affiliation ally, friend 2.7 (1.4)
Achievement win, better 1.9 (1.1)
Power superior, bully 1.5 (.08)
Reward take, benefit 1.5 (0.9)
Risk danger, doubt 0.8 (.07)
Time Orientation
Past focus ago, did 3.2 (1.7)
Present focus today, is 13.8 (2.7)
Future focus may, will 1.5 (1.0)

All reported values are measured in percentages.

In addition, we aimed to identify linguistic predictors of COVID-19-related health anxiety in terms of (a) vigilance to virus-relevant bodily sensations and (b) fears of viral contamination. We hypothesized that the broad LIWC categories of perceptual and biological word processes would predict elevated virus-relevant body vigilance. Specifically, we expected that health-related words would predict elevated virus-relevant body vigilance. In terms of viral contamination fears, we hypothesized that the broad LIWC categories of affective word processes, drives words, and time orientation words would predict greater scores on this measure. Specifically, we hypothesized that both anxiety-related and future-focus words would predict elevated fears of viral contamination.

Methods

Participants

Undergraduate students of at least 18 years of age and enrolled in at least three courses at a large state university in New Jersey completed an online study in response to the COVID-19 pandemic. The university campus closed on March 12, 2020, and data were collected between April 7 and May 9, 2020. The study was administered through Qualtrics, a secure web-based platform. The Qualtrics survey included demographic information (biological sex, age, race, ethnicity, and zip code of current residence), a narrative writing task concerning psychological distress and personal impact of the COVID-19 pandemic (described below), as well as a variety of quantitative self-report instruments, the results of which are reported elsewhere [2123]. Data collection occurred anonymously online. Participants were provided with an IRB-approved anonymous consent form. Participants were then given the opportunity to opt-in (i.e., informed consent) to proceed with the study, which was fully digital and administered through a secure, cloud-based software (e.g., Qualtrics). All procedures were approved by the Rutgers University Institutional Review Board (Approval #PRO2020000808).

Qualitative narrative essay

For the qualitative portion of the study, participants were provided with the following narrative writing prompt instructions:

Please write a paragraph (10–15 sentences) describing how the recent events of the COVID-19 pandemic have caused disruption and/or distress in your daily life. As you write, do not try to censor yourself or block out distressing thoughts or feelings; just notice them as you write and allow them to enrich the details of your paragraph to help us really understand your personal experience.

Participants were also provided with several example questions to help aid in the writing response (e.g., ‘What has been the most stressful or worrisome aspect of the situation for you?). All narratives were required to be at least 1,000 characters in length to ensure adequate descriptive detail; this requirement was unknown to participants unless they attempted to submit a response shorter than the required length, in which case they were prompted to add more detail before proceeding. Average time spent writing was 11.3 minutes (SD = 7.4) and average length of narrative text was 274 words (SD = 106).

Quantitative measures

Three quantitative measures were used to index facets of health anxiety.

Short Health Anxiety Inventory (SHAI)

The SHAI [24, 25] is a 14-item measure that screens for general health anxiety in the past six months. Participants are asked to respond to each item by indicating which of four statements best describes them (e.g., 0 = I do not worry about my health to 3 = I spend most of my time worrying about my health). Scores are added for a total composite score between 0 and 42, with higher scores indicating a higher level of health anxiety. Internal consistency in the current sample was α = .86.

Modified Body Vigilance Scale (BVS)

The BVS [26] is used to assess the degree of attentional focus to bodily sensations related to anxiety in the past week, and item 4 was modified for study purposes to assess vigilance to sensations associated with viral symptoms. Participants rate each item on a scale ranging from 0 (Not at all like me) to 10 (Extremely like me). The fourth item in the scale involves separate ratings for attention to 15 different sensations, which were adapted from the original measure to assess symptoms specifically associated with COVID-19 (i.e., cough, fever, shortness of breath, tiredness, nasal congestion, runny nose, sore throat, aches and pain, diarrhea, chest pain/discomfort, faintness, sweating/clammy hands, upset stomach, nausea, and dizziness). Based on previously established scoring recommendations [27], scores from items 1, 2, and 4 were added for a total between 0 and 30. Internal consistency in the current sample was α = .71.

Fear of Illness and Virus Evaluation—Adult report form (FIVE)

The FIVE [28] is a 35-item self-report measure consisting of four sections. We choose to use only the fears of viral contamination subscale (Part 1) in our analysis, as we considered this scale to be more directly related to the conceptualization of health anxiety as compared to the other subscales. This subscale assesses fears associated with viral illness and contamination (e.g., I am afraid I will get very, very sick if I catch a bad illness or virus). Participants are asked to rate their agreement with each item on a scale ranging from 1 (Not true for me at all, I am not afraid of this at all) to 4 (Definitely true, I am afraid all of the time). Internal consistency in the current sample was α = .89 for Part 1: Fears about Contamination and Illness.

Data analysis

Data screening

A total of 624 participants successfully completed the full survey and provided valid qualitative data, which was screened for abnormalities and outliers. Specifically, participants who spent greater than 1 hour on the narrative essay task were excluded from analyses, due to suspected non-compliance with task instruction (n = 41). In addition, cases with extreme outliers on select narrative indices (described below) were also removed (n = 5). Thus, the final analyzed sample included 578 cases. Narrative #680 was discovered as a duplicate of #677 post-analyses. Consent for publication of raw data was not obtained, but dataset is anonymous in a manner that can easily be verified by any user of the dataset. Publication of the dataset clearly and obviously presents minimal risk to confidentiality of study participants.

Qualitative data processing

Qualitative data were analyzed using LIWC 2015 software [29], which defines over 74 different categories, most of which contain several dozens or hundreds of words. Each narrative was analyzed to determine the percentage of words used from six different LIWC psychological categories relevant to health anxiety (i.e., affective, cognitive, perceptual, biological, time orientation, and drives; see Table 1 for a summary of each LIWC category and the corresponding subcategories). These percentage scores were used as predictor variables in the primary test of the study aims. Given that a high degree of redundancy can occur when including both broad categories and subcategories in the same analysis [30], the broad LIWC categories were analyzed as initial predictors to inform the selection of specific LIWC subcategories to utilize in subsequent analyses.

Quantitative data analyses

Data analyses were conducted using SPSS Version 23.0 (IBM). Quantitative health anxiety indices (i.e., SHAI, BVS, FIVE) were the outcome variables in all analyses. An initial set of backward elimination regression models were conducted to identify the broad LIWC category markers that were predictors of each health anxiety outcome: affective processes, cognitive processes, perceptual processes, biological processes, time orientation, and drives. These retained LIWC categories were used to inform which subcategories to examine in the subsequent prediction model (Fig 1). The selected subcategories within each significant broad category were tested in a multiple regression model. Thus, a total of three initial backward prediction and three multiple regression models were conducted to identify the predictive value of relevant LIWC processes in relation to health anxiety indices.

Fig 1. Backwards regression model of data analysis.

Fig 1

Results

A summary of the main findings is reflected in Table 2, as well as illustrated in Fig 2. The final sample (N = 578) was predominantly female (72.7%) and had a mean age of 20.2 years (SD = 2.19). Participants self-identified their race and ethnicity as white (50.9%), Asian (30.1%), Black or African American (6.7%), other (12.3%), and Hispanic or Latino (14.5%). More than a third of participants (39.1%) reported positive COVID-19 test incidence in their social network and 24.2% reported medical vulnerability to COVID-19.

Table 2. Summary of findings.

Measure Broad LIWC Predictors Subcategory LIWC Predictors
General Health Anxiety Affective Processesa Anxietya
Cognitive Processesb Differentiationb
Drivesb
Virus-Relevant Body Vigilance Affective Processes Anxiety
Time Orientation Future Focusb
Fears of Viral Contamination Affective Processesa Anxietya
Cognitive Processesb Differentiationb; Certainty
Perceptual Processes

aReflects finding consistent with a priori hypotheses.

bReflects a low use of category words in narrative samples as a LIWC predictor of the measure.

Fig 2. Summary of findings.

Fig 2

Mean scores for the quantitative health anxiety measures used in this study are presented in Table 3. All three health anxiety indices were significantly inter-correlated, though not redundant. The SHAI was moderately correlated with the BVS (r = .573, p < .001) and the FIVE (r = .420, p < .001), and the BVS with the FIVE (r = .292, p < .001). Thus, these three measures reflect related, yet distinct aspects of health anxiety.

Table 3. Descriptive statistics of quantitative study measures.

Variable Mean SD Observed Range (Min.) Observed Range (Max.) Possible Range
SHAI 12.4 5.8 1 39 0–42
BVS 12.5 5.6 0 27.6 0–30
FIVE 18.8 6.0 9 36 9–36

SHAI = Short Health Anxiety Inventory; BVS = Adapted Body Vigilance Scale; FIVE = Fear of Illness and Virus Evaluation, Part 1 (Fears of Viral Contamination).

Regression analyses (Table 4)

Table 4. LIWC subcategory predictors of health anxiety, body vigilance, and fears of viral contamination.

General Health Anxiety 95% CI
LIWC Predictors B SE β t p LL UL
Anxiety 1.26 0.24 0.22 5.20 < .001** 0.79 1.74
Anger 0.84 0.57 0.06 1.49 0.138 -0.27 1.96
Sadness 0.20 0.40 0.02 0.49 0.622 -0.59 0.99
Insight 0.15 0.22 0.03 0.71 0.481 -0.27 0.58
Causation 0.06 0.21 0.01 0.26 0.795 -0.36 0.47
Discrepancy 0.47 0.32 0.07 1.48 0.139 -0.15 1.09
Tentative -0.17 0.19 -0.04 -0.91 0.366 -0.55 0.20
Certainty 0.06 0.26 0.01 0.22 0.830 -0.46 0.57
Differentiation -0.49 0.18 -0.12 -2.76 0.006* -0.84 -0.14
Affiliation -0.23 0.18 -0.05 -1.29 0.198 -0.58 0.12
Achieve -0.17 0.23 -0.03 -0.72 0.471 -0.62 0.29
Power -0.32 0.29 -0.05 -1.10 0.270 -0.89 0.25
Reward 0.24 0.28 0.04 0.87 0.382 -0.30 0.78
Risk 0.02 0.37 0.00 0.06 0.955 -0.70 0.74
Virus-Relevant Body Vigilance 95% CI
LIWC Predictors B SE β t p LL UL
Anxiety 0.64 0.23 0.12 2.78 0.006* 0.19 1.10
Anger 0.73 0.54 0.06 1.34 0.180 -0.34 1.80
Sadness 0.02 0.38 0.00 0.05 0.958 -0.73 0.77
Future focus -0.64 0.22 -0.12 -2.87 0.004* -1.08 -0.20
Fears of Viral Contamination 95% CI
LIWC Predictors B SE β t p LL UL
Anxiety 1.14 0.25 0.19 4.60 < .001** 0.65 1.63
Anger -0.41 0.58 -0.03 -0.71 0.481 -1.55 0.73
Sadness 0.18 0.41 0.02 0.43 0.671 -0.64 0.99
See 0.09 0.48 0.01 0.20 0.846 -0.85 1.04
Hear 1.71 0.96 0.07 1.77 0.077 -0.19 3.60
Feel 0.65 0.38 0.08 1.70 0.090 -0.10 1.39
Fears of Viral Contamination 95% CI
LIWC Predictors B SE β t p LL UL
Insight -0.02 0.24 0.00 -0.07 0.943 -0.49 0.46
Causation -0.22 0.22 -0.04 -1.04 0.301 -0.65 0.20
Discrepancy 0.07 0.32 0.01 0.20 0.839 -0.56 0.69
Tentative 0.17 0.20 0.04 0.86 0.389 -0.22 0.55
Certainty 0.70 0.27 0.11 2.62 0.009* 0.18 1.22
Differentiation -0.69 0.18 -0.16 -3.79 < .001** -1.05 -0.33

CI = confidence interval; LL = lower limit; UL = upper limit.

*p < .05.

**p < .001.

General health anxiety

In the initial model, three LIWC categories accounted for 3.0% of variance in SHAI scores assessing general health anxiety (F[3, 574] = 5.96, p < .001), which was driven by high narrative use of affective words and low use of cognitive words and words relating to drives. In the subsequent subcategory predictor model, the LIWC predictors accounted for 7.7% of variance in the SHAI scores (F[14, 563] = 3.34, p < .0001). High use of anxiety-related words and low use of words related to differentiation were predictive of general health anxiety.

Virus-relevant body vigilance

In the initial model, two LIWC categories accounted for 1.9% of variance in the modified BVS scores (F[2, 575] = 5.66, p = .004), which was driven by high use of affective words and low use of future attentional focus words. In the subsequent subcategory predictor model, the LIWC predictors accounted for 2.8% of variance in the virus-related BVS scores (F[4, 573] = 4.11, p = .003). High use of anxiety-related words and low use of words related to future attentional focus were predictive of body vigilance.

Fears of viral contamination

In the initial model, three LIWC categories accounted for 2.3% of variance in the FIVE scores (F[3, 574] = 4.58, p = .004), which was driven by high use of affective and perception words, and low use of cognitive words. In the subsequent subcategory predictor model (Table 4), the LIWC predictors accounted for 9.0% of variance in the FIVE scores (F[12, 565] = 4.68, p < .0001). Specifically, high use of anxiety-related words and certainty-related words, and low use of words related to differentiation, were predictive of viral contamination fears.

Discussion

The purpose of this study was to examine the linguistic predictors of health anxiety in the context of the COVID-19 pandemic, as well as COVID-19-related health anxiety, specific to virus-relevant body vigilance and fears of viral contamination. Both broad and specific linguistic category predictors were analyzed. The results of the present study support the hypothesis that greater general health anxiety was predicted by higher use of words related to affective processes in general, and more specifically, by higher use of anxiety subcategory words. These trends were also reflected in our findings regarding virus-relevant body vigilance and viral contamination fears, which were partially consistent with our original hypotheses.

Our findings are consistent with previous evidence illustrating high use of negative emotion words in narrative writing surrounding viral illness outbreaks, including in the COVID-19 pandemic [14, 15, 31]. Although our study was conducted through a systematic scientific survey format, other studies have examined data that is generated in an unprompted fashion, through analysis of online language platforms such as Weibo [15] and Facebook [14], as well as language used in news reports [15]. It is possible that differences in language use exist when comparing data gathered via systematic, experimental methodology versus data that is generated naturalistically. Future research could examine if differences in language use in online platforms, such as Reddit, may be attributable to participant self-selection bias.

Our results are also consistent with findings of anxious individuals using words related to anxiety [18]. However, the current study is the first to support this finding through written narratives rather than transcribed oral samples (as in Sonnenschein, et al. [18]), marking the first direct demonstration of word use related to affective processes and anxiety as predictors of elevated general health anxiety.

Counter to our original hypothesis, analyses demonstrated that lower use of words related to cognitive processes, specifically, lower use of differentiation words, were predictive of elevated general health anxiety. One explanation for these findings may be linked to the degree of cognitive complexity exhibited by anxious participants. While a higher use of cognitive processes words may indicate a higher degree of cognitive complexity [32], participants with heightened general health anxiety may not be actively differentiating, integrating, or considering solutions to COVID-19-related distress, therefore using low levels of these category words. This theory is further supported by our finding regarding low use of differentiation words as a marker for heightened general health anxiety, indicating that the less participants were making clear distinctions (as exhibited through their writing), the greater their levels of health anxiety.

Limitations

There are at least two potential limitations concerning the results of this study. First, LIWC is unable to detect irony, idioms, sarcasm, or even the issue of multiple meanings of words [33, 34]. Another limitation of LIWC is the matter of word overlap between broad categories and corresponding subcategories, which posed significant issues for the analysis design of the present study. Because LIWC is conceptualized in such a way that any one word may be contained within both a subcategory and a corresponding broad category, the issue of potential overlap exists when selecting word categories for target analysis [29]. The present study was ultimately designed with the intention of avoiding this issue altogether through the strategic use of backwards regression models (Fig 1). A second potential limitation of the current study concerns the low level of variance accounted for by identified linguistic markers. Significant linguistic predictors accounted for 1.9%–9.0% of variance in the health anxiety indices analyzed. Although small effect sizes are common in the context of cognitive and behavioral research [35], it is important to consider the existence of additional mediators that may account for the remaining percentage of variances in the target measures.

Strengths and implications

This study can be seen as a first step toward integrating two lines of research, linguistic analysis and health anxiety (specifically related to COVID-19). Few studies have examined the predictive nature of linguistic features of health anxiety, or of health anxiety in the context of viral illness outbreaks. Thus, these results represent the first direct demonstration of linguistic analysis of health anxiety in the context of the COVID-19 pandemic, as well as COVID-19-related health anxiety specific to virus-relevant body vigilance and fears of viral contamination.

Our results reveal that general health anxiety as well as virus-relevant body vigilance and fears of viral contamination are each driven by high use of emotion-focused language in expressive writing—important not only to the conceptualization of health anxiety experienced as a result of the COVID-19 pandemic, but also to understanding components of health anxiety specific to COVID-19 distress.

We would also like to highlight the data-driven methodological approach used in our analysis of linguistic predictors. This method was carefully formulated in order to avoid the matter of LIWC category overlap and risk for score inflation, as noted in the Limitations section of this paper. This approach increased the construct validity of LIWC as a reliable measure of word use in participant narratives, which may prove useful for future linguistic analyses.

Data Availability

https://osf.io/kfh53.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Kim SW, Su KP. Using psychoneuroimmunity against COVID-19. Brain Behav Immun. 2020. Jul 1;87: 4–5. doi: 10.1016/j.bbi.2020.03.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Marini CM, Pless Kaiser A, Smith BN, Fiori KL. Aging veterans’ mental health and well-being in the context of COVID-19: the importance of social ties during physical distancing. Psychol Trauma. 2020. Aug;12(S1): S217–S219. doi: 10.1037/tra0000736 [DOI] [PubMed] [Google Scholar]
  • 3.Taylor S. COVID stress syndrome: clinical and nosological considerations. Curr Psychiatry Rep. 2021. Apr;23: 1–7. doi: 10.1007/s11920-021-01226-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.American Psychiatric Association. The diagnostic and statistical manual of mental disorders. 5th ed. Text revision. Washington, DC: American psychiatric association; 2013.
  • 5.Tull MT, Barbano AC, Scamaldo KM, Richmond JR, Edmonds KA, Rose JP, et al. The prospective influence of COVID-19 affective risk assessments and intolerance of uncertainty on later dimensions of health anxiety. J Anxiety Disord. 2020. Oct 1;75. doi: 10.1016/j.janxdis.2020.102290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Salkovskis PM, Warwick H. Meaning, misinterpretations, and medicine: A cognitive-behavioral approach to understanding health anxiety and hypochondriasis. In: Starcevic V, Lipsitt DR, editors. Hypochondriasis: Modern perspectives on an ancient malady. Oxford University Press; 2001. pp. 202–222. [Google Scholar]
  • 7.Asmundson GJ, Abramowitz JS, Richter AA, Whedon M. Health anxiety: current perspectives and future directions. Current psychiatry reports. 2010. Aug;12: 306–312. doi: 10.1007/s11920-010-0123-9 [DOI] [PubMed] [Google Scholar]
  • 8.Taylor S. The psychology of pandemics: Preparing for the next global outbreak of infectious disease. Newcastle upon Tyne, UK: Cambridge Scholars Publishing; 2019. [Google Scholar]
  • 9.Abramowitz JS, Olatunji BO, Deacon BJ. Health anxiety, hypochondriasis, and the anxiety disorders. Behav Ther. 2007. Mar 1;38(1): 86–94. doi: 10.1016/j.beth.2006.05.001 [DOI] [PubMed] [Google Scholar]
  • 10.Taylor S, Asmundson GJ. Treating health anxiety: A cognitive-behavioral approach. New York: Guilford Press; 2004. [Google Scholar]
  • 11.Tyrer P, Tyrer H. Health anxiety: detection and treatment. BJPsych Adv. 2018. Jan;24(1): 66–72. [Google Scholar]
  • 12.Salkovskis PM. The importance of behaviour in the maintenance of anxiety and panic: a cognitive account. Behav Cogn Psychother. 1991. Jan;19(1): 6–19. [Google Scholar]
  • 13.Newby JM, O’Moore K, Tang S, Christensen H, Faasse K. Acute mental health responses during the COVID-19 pandemic in Australia. PloS One. 2020. Jul 28;15(7). doi: 10.1371/journal.pone.0236562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Herat M. “I feel like death on legs”: COVID-19 isolation and mental health. Soc Sci Humanit Open. 2020. Jan 1;2(1). doi: 10.1016/j.ssaho.2020.100042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Li S, Wang Y, Xue J, Zhao N, Zhu T. The impact of COVID-19 epidemic declaration on psychological consequences: a study on active Weibo users. Int J Environ Res Public Health. 2020. Mar;17(6). doi: 10.3390/ijerph17062032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Low DM, Rumker L, Talkar T, Torous J, Cecchi G, Ghosh SS. Natural language processing reveals vulnerable mental health support groups and heightened health anxiety on reddit during covid-19: observational study. J Med Internet Res. 2020. Oct 12;22(10). doi: 10.2196/22635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Brockmeyer T, Zimmermann J, Kulessa D, Hautzinger M, Bents H, Friederich HC, et al. Me, myself, and I: self-referent word use as an indicator of self-focused attention in relation to depression and anxiety. Front Psychol. 2015. Oct 9;6. doi: 10.3389/fpsyg.2015.01564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sonnenschein AR, Hofmann SG, Ziegelmayer T, Lutz W. Linguistic analysis of patients with mood and anxiety disorders during cognitive behavioral therapy. Cogn Behav Ther. 2018. Jul 4;47(4): 315–327. doi: 10.1080/16506073.2017.1419505 [DOI] [PubMed] [Google Scholar]
  • 19.Borkovec TD. The nature, functions, and origins of worry. In: Davey G, Tallis F, editors. Worrying: Perspectives on theory, assessment and treatment. Chichester: John Wiley & Sons; 1994. pp. 5–33. [Google Scholar]
  • 20.Geronimi EM, Woodruff-Borden J. The language of worry: examining linguistic elements of worry models. Cogn Emot. 2015. Feb 17;29(2): 311–318. doi: 10.1080/02699931.2014.917071 [DOI] [PubMed] [Google Scholar]
  • 21.Fedorenko EJ, Kibbey MM, Contrada RJ, Farris SG. Psychosocial predictors of virus and social distancing fears in undergraduate students living in a US COVID-19 “hotspot.” Cogn Behav Ther. 2021. May 4;50(3): 217–233. [DOI] [PubMed] [Google Scholar]
  • 22.Kibbey MM, Fedorenko EJ, Farris SG. Anxiety, depression, and health anxiety in undergraduate students living in initial US outbreak “hotspot” during COVID-19 pandemic. Cogn Behav Ther. 2021. Sep 3;50(5): 409–421. doi: 10.1080/16506073.2020.1853805 [DOI] [PubMed] [Google Scholar]
  • 23.Farris SG, Kibbey MM, Fedorenko EJ, DiBello AM. A qualitative study of COVID-19 distress in university students. Emerg Adulthood. 2021. Oct;9(5): 462–478. [Google Scholar]
  • 24.Alberts NM, Hadjistavropoulos HD, Jones SL, Sharpe D. The Short Health Anxiety Inventory: a systematic review and meta-analysis. J Anxiety Disord. 2013. Jan 1;27(1): 68–78. doi: 10.1016/j.janxdis.2012.10.009 [DOI] [PubMed] [Google Scholar]
  • 25.Salkovskis PM, Rimes KA, Warwick HM, Clark D. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002. Jul;32(5): 843–853. doi: 10.1017/s0033291702005822 [DOI] [PubMed] [Google Scholar]
  • 26.Schmidt NB, Lerew DR, Trakowski JH. Body vigilance in panic disorder: evaluating attention to bodily perturbations. J Consult Clin Psychol. 1997. Apr;65(2): 214–220. doi: 10.1037//0022-006x.65.2.214 [DOI] [PubMed] [Google Scholar]
  • 27.Bernstein A, Zvolensky MJ, Sandin B, Chorot P, Stickle TR. Body vigilance: bi‐national examination of the construct. Depress Anxiety. 2008. Oct;25(10): E81–91. doi: 10.1002/da.20330 [DOI] [PubMed] [Google Scholar]
  • 28.Ehrenreich-May J. Fear of Illness and Evaluation Scales. 2020. [Google Scholar]
  • 29.Pennebaker JW, Boyd RL, Jordan K, Blackburn K. The development and psychometric properties of LIWC2015. Austin: University of Texas at Austin; 2015. [Google Scholar]
  • 30.Holtzman NS, Vazire S, Mehl MR. Sounds like a narcissist: behavioral manifestations of narcissism in everyday life. J Res Pers. 2010. Aug 1;44(4): 478–484. doi: 10.1016/j.jrp.2010.06.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tausczik Y, Faasse K, Pennebaker JW, Petrie KJ. Public anxiety and information seeking following the H1N1 outbreak: blogs, newspaper articles, and Wikipedia visits. Health Commun. 2012. Feb 1;27(2): 179–185. doi: 10.1080/10410236.2011.571759 [DOI] [PubMed] [Google Scholar]
  • 32.Tausczik YR, Pennebaker JW. The psychological meaning of words: LIWC and computerized text analysis methods. J Lang Soc Psychol. 2010. Mar;29(1): 24–54. [Google Scholar]
  • 33.Pennebaker JW, Mehl MR, Niederhoffer KG. Psychological aspects of natural language use: our words, our selves. Annu Rev Psychol. 2003. Feb;54(1): 547–577. [DOI] [PubMed] [Google Scholar]
  • 34.Iliev R, Dehghani M, Sagi E. Automated text analysis in psychology: methods, applications, and future developments. Lang Cogn. 2015. Jun;7(2): 265–290. [Google Scholar]
  • 35.Gelman A, Weakliem D. Of beauty, sex and power: too little attention has been paid to the statistical challenges in estimating small effects. Am Sci. 2009. Jul 1;97(4): 310–316. [Google Scholar]

Decision Letter 0

Syed Hassan Ahmed

2 Nov 2023

PONE-D-23-27003Linguistic analysis of health anxiety during the COVID-19 pandemicPLOS ONE

Dear Dr. Farris, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Syed Hassan Ahmed

Guest Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Kindly adjust manuscript formatting in accordance with the journal's guidelines.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors should consider the following.

1. definition of health anxiety (how is it different from anxiety disorder?)

2. definition of covid stress syndrome and adjustment disorder

3. Every paragraph should be starting with ''topic sentence or words''.

4. the authors should consider explaining ''distress vs normal stress'' and the differences in bodily reaction amongst individuals. Exploring other risk factors to distress will also be great.

Reviewer #2: 1. The authors mention excluding "small/limited" responses. It would be helpful, if they can mention that what no of words or characters were deemed as a small response from the participants.

2. The discussion section could highlight studies that covered platform like Reddits (if available for similar domain) and can draw a comparison with your own study as this can also give an insight to future researchers as to which method is more objective or could be explored more. Personal surveys or already posted comments.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Summaiyya Waseem

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Feb 26;19(2):e0299462. doi: 10.1371/journal.pone.0299462.r002

Author response to Decision Letter 0


22 Dec 2023

Manuscript Number: PONE-D-23-27003

Title: Linguistic analysis of health anxiety during the COVID-19 pandemic

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

RESPONSE: We have reviewed the PLOS ONE style templates at the links provided and updated the manuscript to meet the specified requirements, which can be viewed via the “track changes” markup.

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

RESPONSE: We have received approval from our Institutional Review Board that our consent form and protocol as written allow us to share the de-identified study data. Data was uploaded to the Open Science Framework (OSF) repository, and is available here: https://osf.io/kfh53

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

a. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

RESPONSE: We have received approval from our Institutional Review Board that our consent form and protocol as written allow us to share the de-identified study data. Thus, we have removed the language from our paper (line 191): The archived dataset is available from the corresponding author upon reasonable request. Although the collection of personally identifiable information was limited, and no data that can be used to readily identify participants was collected, the researchers do not wish to release the data publicly due to the qualitative nature of participant responses. We replaced this language with the following language: Consent for publication of raw data was not obtained, but dataset is anonymous in a manner that can easily be verified by any user of the dataset. Publication of the dataset clearly and obviously presents minimal risk to confidentiality of study participants.

b. If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide.

RESPONSE: Data was uploaded to the Open Science Framework (OSF) repository, and is available here: https://osf.io/kfh53

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

RESPONSE: We thank the reviewers for noting discrepancy of references cited. A review of the manuscript was conducted to update the reference list. A review of the reference list was then conducted, and no articles were found to be of retracted status. All references are fully cited in the reference list.

Reviewer #1:

1. The authors should consider the following: definition of health anxiety (how is it different from anxiety disorder?)

RESPONSE: We have added clarification on the difference between health anxiety and anxiety disorders through the addition of another paragraph. The revised text reads (line 63) as follows: Health anxiety is characterized by fears of being exposed to and contracting a serious illness, or, the belief that one has already developed a serious disease or medical condition [6]. More broadly, health anxiety can refer to the tendency to over-attend to and become alarmed by health-related stimuli [4], and ranges on a continuum from mild to severe. While mild to moderate health anxiety may be adaptive and lead to engagement in appropriate health and safety measures, people with severe health anxiety frequently exhibit high levels of functional impairment, as well as overutilization of healthcare services [7, 8]. Clinically elevated health anxiety is regularly expressed as persistent worry and maladaptive beliefs about health-related stimuli, along with excessive engagement in subsequent compensatory behaviors (e.g., excessive handwashing, reassurance-seeking). Lifetime prevalence of clinical health anxiety ranges from 1.3% to 10% in the general population, and is exhibited in psychiatric disorders such as illness anxiety disorder and somatic symptom disorder [4].

2. The authors should consider the following: definition of covid stress syndrome and adjustment disorder

RESPONSE: We have added clarification on the definitions of covid stress syndrome and adjustment disorder. The revised text reads (line 57) as follows: While an adjustment disorder marks development of behavioral or emotional symptoms in response to an identifiable stressor—that are out of proportion to the intensity of that stressor [4]—COVID Stress Syndrome is a recently proposed adjustment disorder specific to the SARSCoV2 infection, with identifiable domains including: fear of viral infection, excessive worry about the pandemic, and pandemic-related traumatic stress symptoms [5]. These symptoms share characteristics of health anxiety.

3. The authors should consider the following: Every paragraph should be starting with ''topic sentence or words''.

RESPONSE: We added a topic sentence at line 67 to provide clarity to readers. The revised text reads as follows: Health anxiety is characterized by fears of being exposed to and contracting a serious illness, or, the belief that one has already developed a serious disease or medical condition.

4. The authors should consider the following: the authors should consider explaining ''distress vs normal stress'' and the differences in bodily reaction amongst individuals. Exploring other risk factors to distress will also be great.

RESPONSE: We added the following sentence to line 44 to add clarity to “distress” out of proportion to the norm, as well as to inform risk factors of such distress: Pre-existing daily stressors coupled with the additional stressors associated with the COVID-19 pandemic (e.g., social isolation, financial instability, food insecurity) can create a compounded effect of distress.

Reviewer #2:

1. The authors mention excluding "small/limited" responses. It would be helpful, if they can mention that what no of words or characters were deemed as a small response from the participants.

RESPONSE: Please see lines 172–178, where we define the required criteria for a complete response.

2. The discussion section could highlight studies that covered platform like Reddits (if available for similar domain) and can draw a comparison with your own study as this can also give an insight to future researchers as to which method is more objective or could be explored more. Personal surveys or already posted comments.

RESPONSE: We added the following language to address the topic of language use in other types of platforms, as well as how this may be address in future research (lines 306–312): Although our study was conducted through a systematic scientific survey format, other studies have examined data that is generated in an unprompted fashion, through analysis of online language platforms such as Weibo [14] and Facebook [13], as well as language used in news reports [14]. It is possible that differences in language use exist when comparing data gathered via systematic, experimental methodology versus data that is generated naturalistically. Future research could examine if differences in language use in online platforms, such as Reddit, may be attributed to participant self-selection bias.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0299462.s001.docx (29.5KB, docx)

Decision Letter 1

Syed Hassan Ahmed

18 Jan 2024

PONE-D-23-27003R1Linguistic analysis of health anxiety during the COVID-19 pandemicPLOS ONE

Dear Dr. Farris,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 03 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Syed Hassan Ahmed

Guest Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The use of ''health anxiety'' is still somehow confusing and most professionals trained in mental health might still not be able to understand it. Professionals in mental health and psychiatry communicate either by using Diagnostic and statistical manual (DSM) or the international classification of diseases (ICD). According to the authors definitions of heath anxiety, it might qualify as hypochondriasis or illness anxiety disorder (ICD and DSM 5 respectively). The authors should consider adopting the DSM/ICD nomenclature or adding text to explain the equivalent of health anxiety in ICD or DSM.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: DR ALEX ZUMAZUMA (MBBS, MMED PSYCHIATRY)

Reviewer #2: Yes: Summaiyya Waseem

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Feb 26;19(2):e0299462. doi: 10.1371/journal.pone.0299462.r004

Author response to Decision Letter 1


5 Feb 2024

Reviewer #1:

1. The use of ''health anxiety'' is still somehow confusing and most professionals trained in mental health might still not be able to understand it. Professionals in mental health and psychiatry communicate either by using Diagnostic and statistical manual (DSM) or the international classification of diseases (ICD). According to the authors definitions of heath anxiety, it might qualify as hypochondriasis or illness anxiety disorder (ICD and DSM 5 respectively). The authors should consider adopting the DSM/ICD nomenclature or adding text to explain the equivalent of health anxiety in ICD or DSM.

RESPONSE: We have added clarification on the definition of health anxiety as a transdiasgnostic vulnerability factor exhibited in multiple DSM-5 diagnoses. The revised text reads (line 62) as follows: Clinically elevated health anxiety is regularly expressed as persistent worry and maladaptive beliefs about health-related stimuli, along with excessive engagement in subsequent compensatory behaviors (e.g., excessive handwashing, reassurance-seeking). Lifetime prevalence of clinically elevated health anxiety ranges from 1.3% to 10% in the general population [4]. Studies have shown that elevated health anxiety is a transdiasgnostic vulnerability factor exhibited in multiple DSM-5 psychiatric disorders such as illness anxiety disorder and somatic symptom disorder as well as panic disorder and obsessive-compulsive disorder [4, 5].

Attachment

Submitted filename: Reviewer_Response.docx

pone.0299462.s002.docx (24.4KB, docx)

Decision Letter 2

Syed Hassan Ahmed

12 Feb 2024

Linguistic analysis of health anxiety during the COVID-19 pandemic

PONE-D-23-27003R2

Dear Dr. Farris,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Syed Hassan Ahmed

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Syed Hassan Ahmed

16 Feb 2024

PONE-D-23-27003R2

PLOS ONE

Dear Dr. Farris,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Syed Hassan Ahmed

Guest Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0299462.s001.docx (29.5KB, docx)
    Attachment

    Submitted filename: Reviewer_Response.docx

    pone.0299462.s002.docx (24.4KB, docx)

    Data Availability Statement

    https://osf.io/kfh53.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES